Regeneron Pharmaceuticals Inc. (REGN)

$ 132.17
   
  • Change Today:
    $2.46
  • 52 Week High: $140.01
  • 52 Week Low: $44.96
  • Currency: US Dollars
  • Shares Issued: 93.03m
  • Volume: 824,262
  • Market Cap: $12,296m
  • RiskGrade: 208
  • Beta: 0.78

Latest ShareCast News

Sanofi gets positive results from arthritis drug

Date: Wednesday 13 Jul 2011

Pharmaceutical groups Sanofi and Regeneron Pharmaceuticals announced positive results from the clinical phase IIb study for Sarilumab in the treatment of rheumatoid arthritis.

REGN ShareCast News

No recent information was found.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

REGN Market Data

Currency US Dollars
Share Price $ 132.17
Change Today $ 2.46
% Change 1.90 %
52 Week High $140.01
52 Week Low $44.96
Volume 824,262
Shares Issued 93.03m
Market Cap $12,296m
Beta 0.78
RiskGrade 208

What The Brokers Say

Strong Buy 8
Buy 1
Neutral 8
Sell 0
Strong Sell 0
Total 17
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Trades for 25-May-2012

Time Volume / Share Price
16:00 600 @ $132.17
16:00 3,000 @ $132.17
16:00 10,915 @ $132.17
15:59 300 @ $132.16
15:59 201 @ $132.15

Top of Page